Cancer Prevention Research Institute of Texas — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Cancer Prevention Research Institute of Texas appears in 15 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials15

Recruiting shown1

Roles1

SourceClinicalTrials.gov

Clinical trials

15 shown

Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant AbemaciclibNCT04614194 · collaborator · 2021-04-15

Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery.NCT05113927 · collaborator · 2021-12-01

Wide-field Optical Coherence Tomography Imaging of Excised Breast Tissue.NCT04242277 · collaborator · 2020-08-03

Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)NCT04200534 · collaborator · 2020-07-31

ACTIVE_NOT_RECRUITING

Salud en Mis Manos - Breast and Cervical Cancer Prevention and Early Detection - Expansion 2NCT06082882 · collaborator · 2020-02-20

ACTIVE_NOT_RECRUITING

C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)NCT03635632 · collaborator · 2019-04-23

ACTIVE_NOT_RECRUITING

Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast CancerNCT03747042 · collaborator · 2018-11-27

Promoting Activity in Cancer SurvivorsNCT03060941 · collaborator · 2017-12-04

TACTIC - TAA Specific Cytotoxic T Lymphocytes in Patients With Breast CancerNCT03093350 · collaborator · 2017-10-10

Patient Navigation for Lung Cancer Screening in an Urban Safety-Net SystemNCT02758054 · collaborator · 2017-06-16

Salud en Mis Manos - Breast and Cervical Cancer Prevention and Early Detection - Expansion 1NCT06082505 · collaborator · 2016-11-01

Unidas Por Vida y Salud: Increasing Breast and Cervical Cancer Screening in El PasoNCT04397744 · collaborator · 2015-01-16

Sequencing T-cells in Type I Diabetes MellitusNCT02040337 · collaborator · 2014-04-01

Using a Lay Health Worker Program to Increase Breast and Cervical Cancer Screening in Low-Income Hispanic WomenNCT04426019 · collaborator · 2012-01-12

Increasing Breast, Cervical, and Colorectal Cancer Screening and HPV Vaccination Among Underserved TexansNCT04638010 · collaborator · 2011-02-16

Drugs studied in this sponsor's trials

2 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Cancer Prevention Research Institute of Texas as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

letrozole2

abemaciclib1

letrozole RxCUI 72965 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 2 trials abemaciclib RxCUI 1946825 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial

Sponsor roles

collaborator15

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.